Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Magerl

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
The Journal of Allergy and Clinical Immunology|December 26, 2007
Mast cell-driven skin inflammation is impaired in the absence of sensory nervesFrank Siebenhaar, Markus Magerl, Eva M J Peters, et al.
Clinical and Translational Allergy|September 27, 2024
Advent of oral medications for the treatment of hereditary angioedemaAnna Valerieva, Teresa Caballero, Markus Magerl, et al.
The American Journal of Pathology|May 26, 2007
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependentFrank Siebenhaar, Wolfgang Syska, Karsten Weller, et al.
Frontiers in Medicine|December 19, 2022
Case report: Recurrent angioedema: Diagnosing the rare and the frequentThomas Buttgereit, Lauré M Fijen, Carolina Vera, et al.
Frontiers in Immunology|May 27, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our centerThomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 13, 2018
Nutzen von Mepolizumab bei einer Patientin mit chronischer spontaner UrtikariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 27, 2018
Benefit of mepolizumab treatment in a patient with chronic spontaneous urticariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2009
Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticariaMartin Metz, Ana Giménez-Arnau, Elena Borzova, et al.
Clinical and Translational Allergy|September 25, 2023
Sensitivity to change and minimal clinically important difference of the angioedema control testLauré M Fijen, Carolina Vera, Thomas Buttgereit, et al.
The World Allergy Organization Journal|March 12, 2026
Global research trends in hereditary angioedema, 1972-2023: Bibliometric analysis of productivity, collaboration, and thematic evolutionHugo W F Mak, Hilary J Longhurst, Markus Magerl, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology|December 26, 2007
Mast cell-driven skin inflammation is impaired in the absence of sensory nervesFrank Siebenhaar, Markus Magerl, Eva M J Peters, et al.
Clinical and Translational Allergy|September 27, 2024
Advent of oral medications for the treatment of hereditary angioedemaAnna Valerieva, Teresa Caballero, Markus Magerl, et al.
The American Journal of Pathology|May 26, 2007
Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependentFrank Siebenhaar, Wolfgang Syska, Karsten Weller, et al.
Frontiers in Medicine|December 19, 2022
Case report: Recurrent angioedema: Diagnosing the rare and the frequentThomas Buttgereit, Lauré M Fijen, Carolina Vera, et al.
Frontiers in Immunology|May 27, 2024
The real life experience goes on: update after 4 years on the first cohort treated with lanadelumab at our centerThomas Buttgereit, Carolina Vera Ayala, Seda Aykanat, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 13, 2018
Nutzen von Mepolizumab bei einer Patientin mit chronischer spontaner UrtikariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 27, 2018
Benefit of mepolizumab treatment in a patient with chronic spontaneous urticariaMarkus Magerl, Dorothea Terhorst, Martin Metz, et al.
The Journal of Allergy and Clinical Immunology|January 17, 2009
Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticariaMartin Metz, Ana Giménez-Arnau, Elena Borzova, et al.
Clinical and Translational Allergy|September 25, 2023
Sensitivity to change and minimal clinically important difference of the angioedema control testLauré M Fijen, Carolina Vera, Thomas Buttgereit, et al.
The World Allergy Organization Journal|March 12, 2026
Global research trends in hereditary angioedema, 1972-2023: Bibliometric analysis of productivity, collaboration, and thematic evolutionHugo W F Mak, Hilary J Longhurst, Markus Magerl, et al.
Pageof 16